Notably, in gastric cancer (GC), the overexpression of TGF-β and its receptor TGFBR1 serve as indicators of poor prognosis, especially for patients with high-grade tumors (grade 3) (Figure 1 and Figure 2). This evidence concerns the gene TGFBR1 and gastric cancer.